Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.40 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10854578 | 0.66 | MMP2 (0.42) | L3MBTL1MCOLN3POLBHTTMMP2 | |
| SCHEMBL3621840 | 0.64 | PKM (0.51) | POLBHTTMMP2PKMGAA | |
| SCHEMBL14726921 | 0.64 | MMP2 (0.43) | L3MBTL1POLBHTTMMP2CA1 | |
| SCHEMBL30990322 | 0.64 | PKM (0.43) | L3MBTL1POLBHTTALDH3A1NOD1 | |
| SCHEMBL3579224 | 0.64 | PKM (0.59) | POLBHTTPKMGAAALDH1A1 | |
| SCHEMBL30990289 | 0.63 | ELANE (0.45) | L3MBTL1POLBHTTALDH3A1NOD1 | |
| SCHEMBL18951957 | 0.63 | CA1 (0.53) | L3MBTL1POLBHTTALDH3A1NOD1 | |
| SCHEMBL29001261 | 0.63 | CA1 (0.59) | L3MBTL1POLBHTTALDH3A1NOD1 | |
| SCHEMBL21045977 | 0.62 | CA1 (0.40) | L3MBTL1POLBHTTALDH3A1NOD1 | |
| SCHEMBL16382709 | 0.62 | CA1 (0.53) | L3MBTL1POLBHTTALDH3A1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092065-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | INCYTE CORP (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092065-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | BRD2, BRDT, BRD1 | L3MBTL1 632/4885MCOLN3 1061/4885POLB 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.